Cuba approves emergency use of home-grown Covid vaccine, Latin America's first | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
July 11, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, JULY 11, 2025
Cuba approves emergency use of home-grown Covid vaccine, Latin America's first

Coronavirus chronicle

BSS/AFP
10 July, 2021, 12:50 pm
Last modified: 10 July, 2021, 12:54 pm

Related News

  • US says Cuba 'not fully cooperating' with counter-terrorism efforts
  • Cuba reconnects electrical grid, restores power to much of Havana
  • Cuba's electrical grid collapses, millions without power
  • Biden looks to relax Cuba sanctions in final days before Trump
  • Cuba runs short on fuel at pump as energy crisis festers

Cuba approves emergency use of home-grown Covid vaccine, Latin America's first

Cuba is working on five coronavirus vaccines, and in May started immunizing its population using two of them -- Abdala and Soberana 2 -- even before they received approval

BSS/AFP
10 July, 2021, 12:50 pm
Last modified: 10 July, 2021, 12:54 pm
Photo: BSS/AFP
Photo: BSS/AFP

Cuba on Friday approved its home-grown Abdala vaccine for emergency use, the first Latin American coronavirus jab to reach this stage and a possible lifeline for a region trying to battle a killer pandemic with modest means.

The country's CECMED health regulator gave the go-ahead after Abdala's makers last month announced the vaccine candidate was more than 92 percent effective at preventing Covid-19 disease after three doses.

Cuba is working on five coronavirus vaccines, and in May started immunizing its population using two of them -- Abdala and Soberana 2 -- even before they received approval.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

By this week, 6.8 million of Cuba's 11.2 million people have received at least one dose of either vaccine, while 1.6 million have the required three doses.

The country has not bought or sought vaccines from elsewhere, and aims to immunize its population before the end of the year.

In June, the state-run BioCubaFarma laboratory said Abdala "shows efficacy of 92.28 percent in its three-dose scheme."

The World Health Organization has set a 50-percent efficacy threshold for coronavirus vaccines to qualify for approved global roll-out, though individual countries can green-light jabs without the UN stamp for domestic use.

The CECMED said approval of Abdala was based on its analysis that it met requirements for "quality, safety and effectiveness."

And Aica Laboratories, where the vaccine is produced, said there had been "a rigorous process of evaluation of the dossier and... inspections of the plants involved."

Under American sanctions, communist Cuba has a long tradition of making its own vaccines, dating back to the 1980s.

Nearly 80 percent of its inoculations are produced locally.

- Soberana 2 next? -

On Thursday, the Finlay Institute which makes Soberana 2 said it, too, showed efficacy exceeding 91 percent after three doses.

Eduardo Martinez, president of BioCubaFarma, said Soberana 2 will be submitted to the regulatory authority in the coming days for its own emergency approval.

Cuba has recorded more than 224,000 Covid-19 cases among its population of 11.2 million, and some 1,450 deaths.

It has seen a recent spike in infections, with a new daily infection record reported Friday.

On Wednesday, authorities sent an urgent deployment of doctors and medical equipment to the province of Matanzas -- where foreign tourists have continued to visit -- after hospitals there reached capacity.

A local company has been commissioned to make more hospital beds for Matanzas and there is a social media campaign to raise donations.

Elsewhere in Latin America, the situation remains worrying.

Brazil has the world's second-highest death toll -- more than 530,000. Colombia recently crossed the grim threshold of 100,000 coronavirus deaths and Peru is now the country with the world's highest death toll per capita.

Mexico, whose recorded death toll of 234,000 is the fourth-highest in the world, said Tuesday it is battling a fresh pandemic wave.

A locally produced vaccine offers a glimpse of hope for Latin America and the Caribbean, a region which the UN says has fully vaccinated just over 13.6 percent of its population compared to 34.9 percent in the European Union and 46.3 percent in North America.

The region comprises a third of the world's coronavirus death toll despite representing just 8.4 percent of the global population.

Venezuela has signed a contract to purchase 12 million doses of Abdala and has already started using the Cuban jab in its vaccination campaign.

Argentina's health minister visited the island in May to discuss a possible vaccine deal and Mexico has expressed interest.

There is no requirement for the WHO to approve such bilateral vaccine deals.

Abdala and Soberana 2 are recombinant protein vaccines that work by recreating the "spikes" on the surface of the coronavirus and introducing it to the body, training the immune system to recognize intruders and fight back in case of a real infection.

Recombinant vaccines, unlike some coronavirus shots already in use, do not need extreme refrigeration.

Top News / World+Biz

Cuba / home-grown Covid vaccine / approve

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Kunming rising: China’s emerging healthcare hub draws Bangladeshi patients
    Kunming rising: China’s emerging healthcare hub draws Bangladeshi patients
  • Abul Barkat at Dhaka Metropolitan Magistrate Court on 11 July 2025. Photo: TBS
    Economist Abul Barkat sent to jail in Tk297cr embezzlement case
  • BNP senior leader Salahuddin Ahmed. Photo: Collected
    No scope for electoral alliance with Jamaat, door not closed for NCP: BNP's Salahuddin

MOST VIEWED

  • Photo: Mohammad Minhaj Uddin/TBS
    SSC, equivalent results: Pass rate drops to 68.45%, GPA-5 also declines
  • In terms of stream of education, girls maintained their excellence as well. Photo: TBS
    SSC 2025: Girls dominate boys by over 5%
  • Govt vehicle purchase, foreign trip, new building construction banned: Finance ministry
    Govt vehicle purchase, foreign trip, new building construction banned: Finance ministry
  • Students sit for SSC exam at Motijheel Girls' High School on 10 April 2025. Photo: Mehedi Hasan/TBS
    SSC exam results out: Here's how you can check online and via SMS
  • The overall pass rate across all boards this year, 68.45%, is significantly lower than last year's. Photo: Focus Bangla
    SSC 2025: Rajshahi board records highest pass rate, Barishal lowest
  • Representational image. Photo: Collected
    35% tariff: Bangladesh, US 'agree on most issues' as first day of talks ends

Related News

  • US says Cuba 'not fully cooperating' with counter-terrorism efforts
  • Cuba reconnects electrical grid, restores power to much of Havana
  • Cuba's electrical grid collapses, millions without power
  • Biden looks to relax Cuba sanctions in final days before Trump
  • Cuba runs short on fuel at pump as energy crisis festers

Features

Kunming rising: China’s emerging healthcare hub draws Bangladeshi patients

Kunming rising: China’s emerging healthcare hub draws Bangladeshi patients

37m | Panorama
Photo: Collected/BBC

What Hitler’s tariff policy misfire can teach the modern world

22h | The Big Picture
Illustration: TBS

Behind closed doors: Why women in Bangladesh stay in abusive marriages

1d | Panorama
Purbachl’s 144-acre Sal forest is an essential part of the area’s biodiversity. Within it, 128 species of plants and 74 species of animals — many of them endangered — have been identified. Photo: Syed Zakir Hossain/TBS

A forest saved: Inside the restoration of Purbachal's last Sal grove

1d | Panorama

More Videos from TBS

Trump-Netanyahu in new strategy on Gaza issue

Trump-Netanyahu in new strategy on Gaza issue

27m | TBS World
Shocking science: why birds stay safe on electricity lines

Shocking science: why birds stay safe on electricity lines

1h | TBS Stories
Threat of 35 percent tariff on Canadian goods

Threat of 35 percent tariff on Canadian goods

2h | TBS World
Israel ready to strike back if Iran threatens: Katz

Israel ready to strike back if Iran threatens: Katz

4h | TBS World
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net